The immune response induced by DNA vaccine expressing nfa1 gene against Naegleria fowleri
暂无分享,去创建一个
Sun Park | Ho-Joon Shin | Jong-Hyun Kim | Sang-Hee Lee | Hae-Jin Sohn | Jinyoung Lee | Yong-Joon Chwae | Kyongmin Kim
[1] S. Stanley,et al. Recent progress in vaccines for amebiasis. , 2006, Archives of medical research.
[2] H. Robinson,et al. Nucleic acid vaccines: an overview. , 1997, Vaccine.
[3] P. Bramanti,et al. Acute primary meningoencephalitis from entamoeba Naegleria Fowleri. Report of a clinical case with a favourable outcome. , 1993, Acta neurologica.
[4] D. Warhurst,et al. Primary Amoebic Meningoencephalitis in Britain , 1970, British medical journal.
[5] A. Mustafa. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. , 2001, Current pharmaceutical biotechnology.
[6] S. Ståhl,et al. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. , 1999, Journal of biotechnology.
[7] R. Hernández-Pando,et al. A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver. , 2009, Vaccine.
[8] Sun Park,et al. Production of Nfa1-specific monoclonal antibodies that influences the in vitro cytotoxicity of Naegleria fowleri trophozoites on microglial cells , 2007, Parasitology Research.
[9] Sun Park,et al. Role of the Nfa1 Protein in Pathogenic Naegleria fowleri Cocultured with CHO Target Cells , 2005, Clinical Diagnostic Laboratory Immunology.
[10] Characterization and vaccination of two novel Schistosoma japonicum genes screened from a cercaria cDNA library , 2011, Parasitology Research.
[11] Ho-Joon Shin,et al. Molecular Cloning and Characterization of a Gene Encoding a 13.1 kDa Antigenic Protein of Naegleria fowleri , 2001, The Journal of eukaryotic microbiology.
[12] Kyongmin Kim,et al. Immunological Characterizations of a Cloned 13.1-Kilodalton Protein from Pathogenic Naegleria fowleri , 2003, Clinical Diagnostic Laboratory Immunology.
[13] E. Dumonteil,et al. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells. , 2010, Vaccine.
[14] D. Hollis,et al. Fatty Acid Composition of Neisseria Species as Determined by Gas Chromatography , 1968 .
[15] P. Leone,et al. Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity , 2011, Expert opinion on biological therapy.
[16] R. Strausberg,et al. Characterization and vaccine potential of a novel recombinant coccidial antigen , 1989, Infection and immunity.
[17] G. Acsadi,et al. Direct gene transfer into mouse muscle in vivo. , 1990, Science.
[18] Miller Ad,et al. Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .
[19] K. Anderson,et al. Primary amoebic meningoencephalitis. , 1972, Lancet.
[20] G. B. Karlsson Hedestam,et al. DNA vaccines: recent developments and future possibilities. , 2006, Human gene therapy.
[21] S. Gurunathan,et al. DNA vaccines: a key for inducing long-term cellular immunity. , 2000, Current opinion in immunology.
[22] Ho-Joon Shin,et al. Decreasing effect of an anti-Nfa1 polyclonal antibody on the in vitro cytotoxicity of pathogenic Naegleria fowleri. , 2004, Korean Journal of Parasitology.
[23] G. Visvesvara,et al. Successful treatment of primary amebic meningoencephalitis. , 1982, The New England journal of medicine.
[24] Jan Holmgren,et al. Mucosal immunity and vaccines , 2005, Nature Medicine.
[25] A. Miller,et al. Improved retroviral vectors for gene transfer and expression. , 1989, BioTechniques.
[26] N. Poungvarin,et al. The fifth nonlethal case of primary amoebic meningoencephalitis. , 1991, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[27] W. Poon,et al. Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong , 1993, Clinical Neurology and Neurosurgery.
[28] Z. Hassan,et al. Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii , 2012, Parasitology Research.
[29] G. Visvesvara,et al. Naegleria and Acanthamoeba infections: review. , 1990, Reviews of infectious diseases.
[30] J. Adler-Moore,et al. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. , 1991, The Journal of antimicrobial chemotherapy.
[31] D. Hollis,et al. Fatty Acid Composition of Neisseria Species as Determined by Gas Chromatography , 1968, Journal of bacteriology.
[32] R. Carter,et al. Primary amoebic meningo-encephalitis: An appraisal of present knowledge , 1972 .
[33] J. H. Kim,et al. Effects of immunization with the rNfa1 protein on experimental Naegleria fowleri‐PAM mice , 2011, Parasite immunology.
[34] J. Wilschut,et al. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. , 2001, Vaccine.
[35] J. Mascola,et al. Vaccines for the prevention of HIV-1 disease. , 2001, Current opinion in immunology.
[36] S. Shulman,et al. Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. , 1981, The Journal of infectious diseases.
[37] C. Culbertson. PATHOGENIC NAEGLERIA AND HARTMANNELLA (ACANTHAMOEBA) , 1970, Annals of the New York Academy of Sciences.
[38] G. Dougan,et al. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. , 1999, Immunology today.
[39] Sun Park,et al. Vaccination with Lentiviral Vector Expressing the nfa1 Gene Confers a Protective Immune Response to Mice Infected with Naegleria fowleri , 2013, Clinical and Vaccine Immunology.
[40] K. Dellagi,et al. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice. , 2009, Vaccine.